ACACIA PHARMA LTD FDA Approval NDA 209510

NDA 209510

ACACIA PHARMA LTD

FDA Drug Application

Application #209510

Documents

Label2020-02-26
Letter2020-02-27
Review2020-03-30
Letter2021-01-25
Label2021-01-25
Letter2021-05-26
Label2021-05-27
Label2022-01-06
Letter2022-01-06
Label2022-09-15
Letter2022-09-15

Application Sponsors

NDA 209510ACACIA PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001SOLUTION;INTRAVENOUS5MG/2ML (2.5MG/ML)1BARHEMSYSAMISULPRIDE
002SOLUTION;INTRAVENOUS10MG/4ML (2.5MG/ML)1BARHEMSYSAMISULPRIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2020-02-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2020-09-01N/A
LABELING; LabelingSUPPL3AP2021-05-25STANDARD
LABELING; LabelingSUPPL4AP2021-07-09STANDARD
LABELING; LabelingSUPPL5AP2022-09-14STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL4Null15
SUPPL5Null7

CDER Filings

ACACIA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209510
            [companyName] => ACACIA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BARHEMSYS","activeIngredients":"AMISULPRIDE","strength":"5MG\/2ML (2.5MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"02\/26\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209510s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"02\/26\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209510s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/209510Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2020\\\/209510Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2020-02-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.